The Kenneth Rainin Foundation believes that early support for innovative ideas can lead to improvements in preventing, diagnosing and treating Inflammatory Bowel Disease (IBD). Our investments enable researchers worldwide to test ideas, gather and share data, and collaborate to advance the understanding of IBD. In 2022, we consolidated our Innovator Awards and Synergy Awards into one grant program named Innovator Awards. Grant ranges will remain the same: up to $150,000 for projects by individual researchers and up to $300,000 for collaborative projects involving multiple investigators. Grantees who demonstrate significant progress will be eligible for up to two years of additional support.
Deadline for Letter of Inquiry: Sep. 30, 2022